Abstract
Background: The ecological interactions played by the human microbiota are relevant for the development of neoplasms, either as a risk or a protective factor. The microbiota of the healthy female genital tract is ideally composed of a few microorganisms of the Lactobacillus sp genus. When dysbiosis occurs, there is a decrease in this population and colonization by several bacteria, leading to pathologies. Persistent infection by some types of Human Papillomavirus in the vaginal microbiota is the leading risk factor for developing Cervical Cancer, the fourth leading cause of female cancer mortality in Brazil. Objective: To conduct a narrative review on the ecological interactions between the vaginal microbiota and the development of neoplasms and to discuss the role of the healthy microbiota of the female genital system in cervical cancer development. Method: This narrative review searched for scientific papers on PubMed, Scielo, and Lilacs data platforms using the descriptors: "Vaginal Microbiota", "Dysbiosis" and "Cervical Cancer”. Seventeen articles were selected, including statistical data from the National Cancer Institute, the Pan American Health Organization, and the International Agency for Research on Cancer. Results: When dysbiosis of the vaginal microbiota occurs, anaerobic bacteria can colonize the microbiome and damage the cervical membrane, making it more susceptible to human papillomavirus infection and increasing the risk of tumor formation, as well as causing increased pro-inflammatory cytokines and oxidative damage to biomolecules. These changes can lead to genotoxicity, disruption of cell signaling, and human papillomavirus integration into the host genome, favoring carcinogenesis. Conclusion: Dysbiosis in the cervicovaginal environment may increase susceptibility to the oncogenic potential of human papillomavirus. Further research is needed to increase knowledge of the microorganisms involved and to characterize the vaginal microbiota by epidemiological profiling to prevent and screen for neoplasms.